نتایج جستجو برای: amyloid disaggregation

تعداد نتایج: 39890  

Journal: :The Journal of biological chemistry 2011
Driss El Moustaine Veronique Perrier Isabelle Acquatella-Tran Van Ba Filip Meersman Valeriy G Ostapchenko Ilia V Baskakov Reinhard Lange Joan Torrent

Prion proteins (PrP) can aggregate into toxic and possibly infectious amyloid fibrils. This particular macrostructure confers on them an extreme and still unexplained stability. To provide mechanistic insights into this self-assembly process, we used high pressure as a thermodynamic tool for perturbing the structure of mature amyloid fibrils that were prepared from recombinant full-length mouse...

Journal: :Journal of visualized experiments : JoVE 2011
Elizabeth A Sweeny Morgan E DeSantis James Shorter

Hsp104 is a hexameric AAA+ protein(1) from yeast, which couples ATP hydrolysis to protein disaggregation (Fig. 1). This activity imparts two key selective advantages. First, renaturation of disordered aggregates by Hsp104 empowers yeast survival after various protein-misfolding stresses, including heat shock. Second, remodeling of cross-beta amyloid fibrils by Hsp104 enables yeast to exploit my...

Journal: :مجله علوم اعصاب شفای خاتم 0
mohammad javad imen islamic azad university, mashhad branch, medicine faculty, mashhad, iran reza bayattork islamic azad university, mashhad branch, medicine faculty, mashhad, iran

alzheimer disease (ad) is a neurodegenerative disorder marked by cognitive and behavioral impairment. amyloid beta (aβ) peptides are involved in ad as the main component of amyloid plaques found in the brain. recent in vivo and in vitro studies have shown that there is a lot of substances that alter aβ pathogenesis of ad. aβ induces toxicity lead to increasing ros. in the other hand, 5-ht6 and ...

2009
Shilpa Vashist Mimi Cushman James Shorter

Hsp104, a hexameric AAA+ ATPase found in yeast, transduces energy from cycles of ATP binding and hydrolysis to resolve disordered protein aggregates and cross-b amyloid conformers. These disaggregation activities are often co-ordinated by the Hsp70 chaperone system and confer considerable selective advantages. First, renaturation of aggregated conformers by Hsp104 is critical for yeast survival...

2016
Mark Ultsch Bing Li Till Maurer Mary Mathieu Oskar Adolfsson Andreas Muhs Andrea Pfeifer Maria Pihlgren Travis W. Bainbridge Mike Reichelt James A. Ernst Charles Eigenbrot Germaine Fuh Jasvinder K. Atwal Ryan J. Watts Weiru Wang

Accumulation of amyloid-β (Aβ) peptides and amyloid plaque deposition in brain is postulated as a cause of Alzheimer's disease (AD). The precise pathological species of Aβ remains elusive although evidence suggests soluble oligomers may be primarily responsible for neurotoxicity. Crenezumab is a humanized anti-Aβ monoclonal IgG4 that binds multiple forms of Aβ, with higher affinity for aggregat...

Journal: :Natural Product Communications 2022

In an aging society, the prevalence of Alzheimer disease (AD) and type 2 diabetes (T2D) has increased. It is currently hypothesized that these diseases are caused by aggregation amyloid β (Aβ) in brain human islet polypeptide (hIAPP) islets Langerhans, respectively. Therefore, disaggregation existing aggregates a promising approach to prevention treatment both diseases. our previous studies, we...

2017
Jungsoon Lee Nuri Sung Lythou Yeo Changsoo Chang Sukyeong Lee Francis T.F. Tsai

The ring-forming Hsp104 ATPase cooperates with Hsp70 and Hsp40 molecular chaperones to rescue stress-damaged proteins from both amorphous and amyloid-forming aggregates. The ability to do so relies upon pore loops present in the first ATP-binding domain (AAA-1; loop-1 and loop-2 ) and in the second ATP-binding domain (AAA-2; loop-3) of Hsp104, which face the protein translocating channel and co...

Journal: :PLoS Medicine 2005
Joanna L Jankowsky Hilda H Slunt Victoria Gonzales Alena V Savonenko Jason C Wen Nancy A Jenkins Neal G Copeland Linda H Younkin Henry A Lester Steven G Younkin David R Borchelt

BACKGROUND The proteases (secretases) that cleave amyloid-beta (Abeta) peptide from the amyloid precursor protein (APP) have been the focus of considerable investigation in the development of treatments for Alzheimer disease. The prediction has been that reducing Abeta production in the brain, even after the onset of clinical symptoms and the development of associated pathology, will facilitate...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید